Puma Biotechnology PBYI
NASDAQ PBYI
$8.08 -0.06 (-0.74%)
At close: Nov 11, 2026 · 4:00 PM EST

Puma Biotechnology (PBYI) Return on Sales [ROS] (2017 - 2026)

Updated

Puma Biotechnology's Return on Sales [ROS] was 13.42% in Q2 2026, up 0.77 percentage points from 12.66% a year earlier and up 21.97 percentage points from the prior quarter.

Analysis

Puma Biotechnology (PBYI) Return on Sales [ROS] (2017 - 2026) Analysis & Trends

On a trailing twelve-month basis, Puma Biotechnology's Return on Sales [ROS] was 13.16% through Jun 30, 2026, down 6.19 percentage points year-over-year; for FY2025, it was 16.33%, up 2.90 percentage points from FY2024.

  • Return on Sales [ROS] shows a five-year change of +29.84 percentage points (FY2020 to FY2025).
  • In earlier years, Return on Sales [ROS] was 13.44% in FY2024 (-0.42 pp), 13.85% in FY2023 (+3.45 pp), 10.40% in FY2022 (+9.89 pp) and 0.51% in FY2021 (+14.01 pp).
  • Quarterly Return on Sales [ROS] has moved between -19.36% (Q3 2021) and 27.41% (Q3 2024) over five years.
  • Compared with a year earlier, Return on Sales [ROS] was higher in six of the last eight quarters, with an average year-over-year change of +2.40 percentage points.
  • The best year-over-year quarter for Return on Sales [ROS] over five years was Q2 2022 (a gain of 51.42 percentage points); the worst was Q1 2022 (a drop of 22.16 percentage points).
  • Per Business Quant data, PBYI's Return on Sales [ROS] in the three quarters before Q2 2026 was -8.54% (Q1 2026), 22.67% (Q4 2025) and 17.57% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 34.46%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 24.35%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 36.01%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 30.74%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 29.12%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 35.79%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 41.71%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 32.98%
10 Puma Biotechnology 420.82 Mn 19.27 Mn 39.86 Mn 9.58%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 9.58%
Jun 30, 2026 13.42%
Mar 31, 2026 -8.54%
Dec 31, 2025 22.67%
Sep 30, 2025 17.57%
Jun 30, 2025 12.66%
Mar 31, 2025 8.66%
Dec 31, 2024 22.62%
Sep 30, 2024 27.41%
Jun 30, 2024 -4.63%
Mar 31, 2024 -5.25%
Dec 31, 2023 20.50%
Sep 30, 2023 15.30%
Jun 30, 2023 8.96%
Mar 31, 2023 8.27%
Dec 31, 2022 15.25%
Sep 30, 2022 4.19%
Jun 30, 2022 20.26%
Mar 31, 2022 -1.63%
Dec 31, 2021 12.34%
API Access

Puma Biotechnology Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=PBYI&period=max&api_key=YOUR_API_KEY